Instylla Announces Completion of Series B Financing
Financing to see Instylla through US Pivotal and other clinical trials BEDFORD, Mass., Oct. 14, 2020 /PRNewswire/ — Instylla, Inc., a privately held
Pioneering Medical Innovations
Pioneering Medical Innovations
Financing to see Instylla through US Pivotal and other clinical trials BEDFORD, Mass., Oct. 14, 2020 /PRNewswire/ — Instylla, Inc., a privately held
Funds to Fuel Commercialization of Breakthrough Technologies in Stroke Care to Enable Improved Patient Outcomes CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc.
CAMPBELL, Calif., Jan. 13, 2015 /PRNewswire/ — Apama Medical, Inc., a privately held medical device company focused on the development of
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was
Agreement creates opportunity for improving outcomes in radiation oncology PALO ALTO, Calif. and WALTHAM, Mass., May 12, 2011 /PRNewswire/ —
WALTHAM, Mass., Oct. 16 /PRNewswire/ — Augmenix announced today that it has closed a $6.1 million Series B financing. The
I-Therapeutix announced today that it has closed a $15million dollar Series C financing. The round was led by Polaris Venture